Every year, Merck's research division held a large review meeting at which all research programs were examined.
Onchocerciasis river blindness. On the other hand, because such a significant amount of money had already been invested m the development of the animal drug, the cost of developing a human formulation would be much less than that for developing a new compound.
The organization will distribute the drug within the countries involved. In Latin America, S. Newer lactones in development include moxidectin that has shown some potential as a macrofilaricide.
From then untilseveral human clinical trials demonstrating the efficacy of ivermectin to treat river blindness were conducted in several African countries. From this bacterium, sent by Kitasato to Merck in accord with their contractual agreement, Merck scientists led by Dr.
Many variations would likely follow: drugs for sheep and pigs, horses, dogs, and others.